Serial Infusions of Allogeneic Mesenchymal Stem Cells in Cardiomyopathy Patients With Left Ventricular Assist Device (STEM-VAD)
A Randomized, Double-Blind, Placebo-Controlled Phase IIa Study of the Safety and Efficacy of Intravenous Delivery of Allogeneic Mesenchymal Stem Cells in Cardiomyopathy Patients and Implanted Left Ventricular Assist Device
Sponsor: Medstar Health Research Institute
Terminated
Lack of funding/Covid-19
Other terminated trials from Medstar Health Research Institute
A PHASE2 clinical study on Ischemic Heart Disease and Non-ischemic Cardiomyopathy, this trial is terminated or withdrawn. The trial is conducted by Medstar Health Research Institute and has accumulated 10 data snapshots since 2019. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Mar 2022 — Jul 2024 [monthly]
Terminated PHASE2
Status: Active Not Recruiting → Terminated
-
Jan 2021 — Mar 2022 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
▶ Show 5 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Feb 2020 — Sep 2020 [monthly]
Recruiting PHASE2
-
Sep 2019 — Feb 2020 [monthly]
Recruiting PHASE2
-
Jun 2019 — Sep 2019 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
May 2019 — Jun 2019 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Medstar Health Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .